Kidney outcomes associated with sodium-glucose cotransporter 2 inhibitors versus glucagon-like peptide 1 receptor agonists: A real-world population-based analysis

by Au, I.C.H, Cheung, C.L, Lee, C.H, Lui, D.T.W, Tan, K.C.B, Tang, E.H.M, Wong, C.K.H, Woo, Y.C, Wu, T.
Published 2022

Bariatric Surgery: It's Not Just Incretins!

by Ferraz-Bannitz, R., Kashyap, S., Patti, M.E
Published 2022

Mitofusins Mfn1 and Mfn2 Are Required to Preserve Glucose- but Not Incretin-Stimulated β-Cell Connectivity and Insulin Secretion

by Akalestou, E., Ali, Y., Alsabeeh, N., Chabosseau, P., Cruciani-Guglielmacci, C., Georgiadou, E., Gu, G., Ibberson, M., Jones, B., Leclerc, I., Legido-Quigley, C., Linnemann, A.K, Lopez-Noriega, L., Magnan, C., Martinez, M., Muralidharan, C., Rodriguez, T.A, Rutter, G.A, Soleimanpour, S.A, Stylianides, T., Tomas, A., Wern, F.Y.S, Wretlind, A., Xu, Y.
Published 2022